These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15390009)
21. Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures. Jamora RD; Diesta CC; Pasco PM; Lee LV Int J Neurosci; 2011; 121 Suppl 1():18-21. PubMed ID: 21244304 [TBL] [Abstract][Full Text] [Related]
22. Temporal bone histopathologic and genetic studies in Mohr-Tranebjaerg syndrome (DFN-1). Merchant SN; McKenna MJ; Nadol JB; Kristiansen AG; Tropitzsch A; Lindal S; Tranebjaeizrg L Otol Neurotol; 2001 Jul; 22(4):506-11. PubMed ID: 11449109 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Valente EM; Misbahuddin A; Brancati F; Placzek MR; Garavaglia B; Salvi S; Nemeth A; Shaw-Smith C; Nardocci N; Bentivoglio AR; Berardelli A; Eleopra R; Dallapiccola B; Warner TT Mov Disord; 2003 Sep; 18(9):1047-51. PubMed ID: 14502674 [TBL] [Abstract][Full Text] [Related]
24. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Swerdlow RH; Wooten GF Ann Neurol; 2001 Oct; 50(4):537-40. PubMed ID: 11601506 [TBL] [Abstract][Full Text] [Related]
25. Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome. Brookes JT; Kanis AB; Tan LY; Tranebjaerg L; Vore A; Smith RJ Int J Pediatr Otorhinolaryngol; 2008 Jan; 72(1):121-6. PubMed ID: 17936919 [TBL] [Abstract][Full Text] [Related]
26. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology. Engl G; Florian S; Tranebjærg L; Rapaport D Hum Mol Genet; 2012 Jan; 21(2):287-99. PubMed ID: 21984432 [TBL] [Abstract][Full Text] [Related]
27. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. Tezenas du Montcel S; Clot F; Vidailhet M; Roze E; Damier P; Jedynak CP; Camuzat A; Lagueny A; Vercueil L; Doummar D; Guyant-Maréchal L; Houeto JL; Ponsot G; Thobois S; Cournelle MA; Durr A; Durif F; Echenne B; Hannequin D; Tranchant C; Brice A; J Med Genet; 2006 May; 43(5):394-400. PubMed ID: 16227522 [TBL] [Abstract][Full Text] [Related]
28. The monogenic primary dystonias. Müller U Brain; 2009 Aug; 132(Pt 8):2005-25. PubMed ID: 19578124 [TBL] [Abstract][Full Text] [Related]
29. The syndrome of deafness-dystonia: clinical and genetic heterogeneity. Kojovic M; Pareés I; Lampreia T; Pienczk-Reclawowicz K; Xiromerisiou G; Rubio-Agusti I; Kramberger M; Carecchio M; Alazami AM; Brancati F; Slawek J; Pirtosek Z; Valente EM; Alkuraya FS; Edwards MJ; Bhatia KP Mov Disord; 2013 Jun; 28(6):795-803. PubMed ID: 23418071 [TBL] [Abstract][Full Text] [Related]
30. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Foncke EM; Gerrits MC; van Ruissen F; Baas F; Hedrich K; Tijssen CC; Klein C; Tijssen MA Neurology; 2006 Nov; 67(9):1677-80. PubMed ID: 17101905 [TBL] [Abstract][Full Text] [Related]
31. First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia. Plummer C; Bradfield J; Singleton AB; Hernandez D; Singleton AA; O'sullivan J J Clin Neurosci; 2005 Nov; 12(8):945-6. PubMed ID: 16242937 [TBL] [Abstract][Full Text] [Related]
32. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Asmus F; Hjermind LE; Dupont E; Wagenstaller J; Haberlandt E; Munz M; Strom TM; Gasser T Brain; 2007 Oct; 130(Pt 10):2736-45. PubMed ID: 17898012 [TBL] [Abstract][Full Text] [Related]
33. Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease. Howe LL; Kellison IL; Fernandez HH; Okun MS; Bowers D Clin Neuropsychol; 2009 Jan; 23(1):100-17. PubMed ID: 18609312 [TBL] [Abstract][Full Text] [Related]
34. [A case of juvenile onset ataxia with dystonia, myoclonus, sensorineural hearing loss and mental retardation]. Koide R; Yoshimura N; Soma Y; Tsuji S Rinsho Shinkeigaku; 1993 Aug; 33(8):909-11. PubMed ID: 8261707 [TBL] [Abstract][Full Text] [Related]
36. [Clinical and physiological analysis and treatment of writer's cramp]. Shavlovskaia OA; Orlova OR; Golubev VL; Veĭn AM Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(10):35-41. PubMed ID: 12449563 [TBL] [Abstract][Full Text] [Related]
37. Opsoclonus-myoclonus syndrome attributable to hepatitis C infection. Ertekin V; Tan H Pediatr Neurol; 2010 Jun; 42(6):441-2. PubMed ID: 20472199 [TBL] [Abstract][Full Text] [Related]